Keywords: Raloxifene; SERM; Periodontitis; Postmenopausal osteoporosis;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: MD-TESE; microdissection testicular sperm extraction; TESE; testicular sperm extraction; TESA; testicular sperm aspiration; SRR; sperm recovery rate; ICSI; intracytoplasmic sperm injection; NOA; non-obstructive azoospermia; OA; obstructive azoospermia; hC
Keywords: CC; clomiphene citrate; E2; oestradiol; hCG; human chorionic gonadotrophin; hMG; human menopausal gonadotrophin; HPG; hypothalamic-pituitary-gonadal; PRISMA; Preferred Reporting Items for Systemic Reviews and Meta-Analyses; SERM; selective oestrogen r
Keywords: AR; androgen receptor; ARE; androgen response element; ChIP; chromatin immunoprecipitation; DHT; dihydrotestosterone; ER; estrogen receptor; ERE; estrogen response element; E2; 17β-estradiol; T; testosterone; DES; diethylstilbestrol; BPA; bisphenol A; SE
Keywords: 27-HC; 27-Hydroxycholesterol; 3PO; 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one; ABCG1; ATP-binding cassette subfamily G1; ACBA1; ATP-binding cassette subfamily A1; ACC1; Acetyl-Co-A carboxylase-1; AKAP4; A-kinase anchoring protein 4; ALDO; Aldolase; AM
Keywords: AF; S-triethyl phosphine gold(I)-2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside (Auranofin); AP-1; activator protein 1; ARE; antioxidant response element; ASK1; apoptosis signal-regulating kinase 1; [Au(dppe)2]Cl; [bis(diphenylphosphino)ethane]gold(I)
Keywords: Oxysterols; Cancer; Polymorphism; Risk; Genetics; Cholesterol; 25(OH)D; 25-hydroxyvitamin D; ABC; ATP-binding cassette; AEBS; antiestrogen-binding site; BC; breast cancer; BCR; biochemical recurrence; CETP; cholesteryl ester transfer protein; CH25H; chole
Keywords: AI; aromatase inhibitor; DHEA; dehydroepiandrosterone; ET; estrogen therapy; FDA; US Food and Drug Administration; GSM; genitourinary syndrome of menopause; SERM; selective estrogen receptor modulator;
Keywords: Phytoestrogens; SERM; Breast cancer cell lines; PC12; Proliferation; Differentiation;
27-hydroxycholesterol: A novel player in molecular carcinogenesis of breast and prostate cancer
Keywords: 27-OHC; 27-hydroxycholesterol; ADT; androgen deprivation therapy; AR; androgen receptor; ATF4; Activating Transcription Factor 4; ATF6; Activating Transcription Factor 6; C/EBP; CCAAT / Enhancer binding proteins; CHOP; C/EBP homologous protein; CIP2A; can
Keywords: AOM; anti osteoporotic medications; IOF; International Osteoporosis Foundation; NOF; National Osteoporosis Foundation; HIRA-APS; Health Insurance Review and Assessment Service-Adult Patient Sample; HIRA; Health Insurance Review and Assessment Service; ICD
Keywords: BC; Breast cancer; CRM-1; Chromosome region maintenance 1; DBD; DNA-binding domain; E2; 17-beta-estradiol; EGF; Epidermal growth factor; ERα; Estrogen receptor alpha; Ful; Fulvestrant; GFP-ER; ER tagged with green fluorescent protein; HSP70; Heat shock p
Keywords: ADT; androgen deprivation therapy; AR; androgen receptor; ASO; antisense oligonucleotide; CARN; castration-resistant Nkx3.1 expressing cells; CK; cytokeratin; CRPC; castration-resistant prostate cancer; DMBA; 7,12-dimethylbenz[a]anthracene; ECM; extracell
Keywords: 3-BC; 3-benzylidene camphor; 4-MBC; 4-methylbenzylidene camphor; Aβ; amyloid-β; ABAD; Aβ-binding alcohol dehydrogenase; AD; Alzheimer's disease; AI; aromatase inhibitor; AKR; aldo-keto reductase; AME; apparent mineralocorticoid excess; AR; androgen r
Keywords: 27-Hydroxycholesterol; Oxysterol; Estrogen receptor; SERM; LXR
Keywords: [Ca++]i; intracellular Ca2+ concentration; 2ME2; 2-methoxyestradiol, a natural metabolite of estradiol; 4-OH-Tmx; 4-hydroxytamoxifen, a metabolite of Tmx; 5-HT3R; 5-hydroxytryptamine receptor subtype 3; AMPAR; α-amino-3-hydroxy-5-methyl-4-isoxazolepropio
Keywords: Raloxifene; SERM; Collagen; Bone powder
Keywords: CBT; cognitive behavioral therapy; CYP2D6; cytochrome P450 2D6; DHEA; dehydroepiandrosterone; FDA; Food and Drug Administration; GSM; genitourinary syndrome of menopause; MPA; medroxyprogesterone acetate; SERM; selective estrogen receptor modulator; SGB;
Keywords: Sulfatase; Enzyme; Inhibitor; Estrogen; Cancer; SERM; ALP; alkaline phosphatase; DEA; diethylamine; DHEA; dehydroepiandrosterone; DHEAS; dehydroepiandrosterone sulfate; 5-diol; 5-androstene-3β,17β-diol; DIPEA; diisopropylamine; E1; estrone; E1S; estrone
Keywords: ACE; angiotensin converting enzyme inhibitors; AI; aromatase inhibitors; BC; breast cancer; DCIS; ductal carcinoma in situ; CVD; cardiovascular disease; ESC; European society of cardiology; GLS; global longitudinal strain; HFpEF; heart failure with preser
Keywords: Estrogen receptor; Partial agonist; SERM; Carborane
Keywords: SL; sphingolipid; S1P; sphingosine 1-phosphate; GCS; glucosylceramide synthase; GC; glucosylceramide; AC; ceramidase; SphK; sphingosine kinase; PPMP; D-threo-1-phenyl-2-hexadecanoylamino-3-morpholino-1-propanol; PDMP; D-threo-1-phenyl-2-decanoylamino-3-mo
Keywords: AR; androgen receptor; CAR; constitutive androstane receptor; DBD; DNA-binding domain; EDC; endocrine disrupting chemical; ER; estrogen receptor; FXR; farnesoid X receptor; GR; glucocorticoid receptor; HRE; hormone responsive elements; LBD; ligand-binding
Keywords: AA; arachidonic acid; aP2 (or FABP4); adipocyte protein 2; BMD; bone mass density; BMP-2; bone morphogenic protein-2; CE; cholesterol esters; CHL; cholesterol; cAMP; cyclic 3,5-adenosine monophosphate; CLA; conjugated isomers of linoleic acid; COX; cycloo
Keywords: BSA; bovine serum albumin; E2; 17β-estradiol; ER; estrogen receptor; ERAB; estrogen receptor autoantibodies; ERαAB; estrogen receptor α autoantibodies; ERβAB; estrogen receptor β autoantibodies; ERK; extracellular signal-regulated kinase; GPR30; G pr
Keywords: Cancer; Breast; Prevention; AntihormonesCancer du sein; Inhibiteur de l’aromatase; SERM; Prévention
Keywords: ChIP; chromatin immunoprecipitation; E2; 17β-estradiol; ERα; estrogen receptor alpha; ERBS; estrogen receptor α binding site; eRNA; enhancer RNA; GRO-seq; global nuclear run-on and sequencing; HMM; hidden Markov model lncRNA, long non-coding RNAs; mRNA
Keywords: VVA; vulvovaginal atrophy; SERM; selective estrogen receptor modulator; NDA; new drug application; FDA; Food and Drug Administration; NSABP; National Surgical Adjuvant Breast & Bowel Project; STAR; Study of Tamoxifen and Raloxifene; ER; estrogen receptor;
Keywords: SERM; selective estrogen receptor modulator; BRCAT; breast cancer risk assessment tool; IBIS; International Breast Cancer Intervention Study Model; NSAID; non-steroidal anti-inflammatory; DCIS; ductal carcinoma in situ; OVX; ovariectomy; Tamoxifen; Postpa
Keywords: BMD; bone mineral density; BZA; bazedoxifene; CE; conjugated estrogens; EPT; estrogen-progestin therapy; ER; estrogen receptor; LAS; lasofoxifene; LDL-C; low-density lipoprotein cholesterol; MCF-7; Michigan Cancer Foundation-7; MENQOL; Menopause-Specific
Keywords: BMD; bone mineral density; SERM; selective estrogen receptor modulator; MA; metabolic acidosis; CONT; control; RAL; raloxifene; ZOL; zoledronate; Sup; Superficial; Int; Intermediate; Ctr; Central; HA; hydroxyapatite; SHG; second harmonic generation; FTIR;
Keywords: AD; Alzheimer's disease; AQP; aquaporin; ATP; adenosine triphosphate; BBB; blood-brain barrier; BSA; bovine serum albumin; CaMK; Ca2+/calmodulin-dependent protein kinases; CNS; central nervous system; EAE; experimental autoimmune encephalomyelitis; ER;
A ferutinin analogue with enhanced potency and selectivity against ER-positive breast cancer cells in vitro
Keywords: 3D; three dimensions; BC; breast cancer; BCSCs; breast cancer stem cells; Ca2+; calcium; CSCs; cancer stem cells; CTL; control; E2; 17β-estradiol; EDTA; ethylenediaminetetraacetic acid; ER; estrogen receptors; FBS; foetal bovine serum; FRT; ferutinin; HA
Role of GPER in estrogen-dependent nitric oxide formation and vasodilation
Keywords: eNOS; Estrogen; Endothelium; GPER; GPR30; NO; SERD; SERM; Vascular; Vasodilation;
Selective Estrogen Receptor Modulator and prostimulatory effects of phytoestrogen β-ecdysone in Tinospora cordifolia on osteoblast cells
Keywords: Ã-ecdysone; Tinospora cordifolia; SERM; Phytoestrogens; Osteoblasts; Osteoporosis;
6,7,4â²-Trihydroxyisoflavone suppressed the estrogen receptor negative breast cancer growth via regulating glycogen synthase kinase-3β/β-catenin signaling
Keywords: Breast cancer; β-catenin; Cell cycle; Glycogen synthase kinase-3β; Trihydroxyisoflaovone; CDK; cyclin dependent kinase; CDKI; cyclin dependent kinase inhibitor; ER; estrogen receptor; ERK; extracellular signal-regulated kinase; GSK; glycogen synthase ki
The tamoxifen derivative ridaifen-B is a high affinity selective CB2 receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects
Keywords: Cannabinoid receptors; G-protein coupled receptors; Inverse agonist; Antagonist; Drug action; AC; adenylyl cyclase; CB1R; cannabinoid receptor type 1; CB2R; cannabinoid receptor type 2; CHO; Chinese hamster ovary; CP-55,940; 5-(1,1-dimethylheptyl)-2-[5-hy
Increase in hyaluronic acid degradation decreases the expression of estrogen receptor alpha in MCF7 breast cancer cell line
Keywords: Estrogen signaling; Hyaluronic acid; Hyaluronidase; Breast cancer; Hormonal therapy resistance; CD44; cluster of differentiation 44; CV; crystal violet; E2; 17β-estradiol; ECM; extracellular matrix; EMT; epithelial-mesenchymal transition; ER; estrogen re
Effects of a tissue-selective estrogen complex on B lymphopoiesis and B cell function
Keywords: Bazedoxifene; Estradiol; SERM; Tissue-selective estrogen complex (TSEC); Lymphopoiesis; Antibody production;
Bioactivity guided isolation of phytoestrogenic compounds from Cyclopia genistoides by the pER8:GUS reporter system
Keywords: HRT; hormone replacement therapy; CEE; conjugated equine estrogen; CEE + P; conjugated equine estrogen in combination with progestin; SERM; selective estrogen receptor modulators; ER; α and β estrogen receptors; E2; 17-β-estradiol; XVE; estrogen rece
MTA1 expression in human cancers - Clinical and pharmacological significance
Keywords: MTAs; metastasis associated proteins; EMT; epithelial to mesenchymal transition; NuRD; nuclear remodeling and deacetylation complex; HDAC1 or HDAC2; histone deacetylases; MBD; methylated CpG binding domain proteins; RbAb46/48; retinoblastoma associated pr
Treatment of estrogen-dependent diseases: Design, synthesis and profiling of a selective 17β-HSD1 inhibitor with sub-nanomolar IC50 for a proof-of-principle study
Keywords: 17β-Hydroxysteroid dehydrogenase type 1; Enzyme inhibitor; Steroidogenic enzymes; Estrogen-dependent disease; Intracrinology; (h)17β-HSD1; (human) 17β-hydroxysteroid dehydrogenase type 1; (h)17β-HSD2; (human) 17β-hydroxysteroid dehydrogenase type 2;
3-Piperidylethoxypterocarpan: A potential bone anabolic agent that improves bone quality and restores trabecular micro-architecture in ovariectomized osteopenic rats
Keywords: Benzofurochromene; Bone anabolic agent; Osteoporosis; Ovariectomized; BMP-2 activator; BFC; 6H-benzofuro[3,2-c] chromenes; BMD; bone mineral density; MAR; mineral apposition rate; BFR; bone formation rate; SERM; selective estrogen receptor modulators; PTH
The ROS-mediated activation of IL-6/STAT3 signaling pathway is involved in the 27-hydroxycholesterol-induced cellular senescence in nerve cells
Keywords: 27HC; 27-hydroxycholesterol; SERM; selective estrogen receptor modulator; E2; 17β-estradiol; ROS; Reactive oxygen species; STAT3; Signal transducer and activator of transcription 3; NAC; N-acetylcysteine; SA-β-Gal; Senescence-associated b-galactosidase;
Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study
Keywords: BC; breast cancer; Tam; tamoxifen; AEBS; antiestrogen binding site; ET; endocrine therapy; OS; oxysterol; AI; aromatase inhibitors; 24-HC; 24-hydroxycholesterol; 25-HC; 25-hydroxycholesterol; 27-HC; 27-hydroxycholesterol; 7α-HC; 7α-hydroxycholesterol; 7
Ginkgo biloba extract EGb 761-mediated inhibition of aromatase for the treatment of hormone-dependent breast cancer
Keywords: EGb 761; Breast cancer; Aromatase inhibitor; Aromatase promoters; 17β-estradiol biosynthesis; Xenograft; AI; aromatase inhibitor; DMEM; dulbecco's modified eagle's medium; DMSO; dimethyl sulfoxide; FBS; fetal bovine serum; GBE; Ginkgo biloba extract; PBS
Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta
Keywords: OI; Bone mechanical properties; SERM; Oim/oim
Dynamic monitoring of GPER-mediated estrogenic effects in breast cancer associated fibroblasts: An alternative role of estrogen in mammary carcinoma development
Keywords: α-SMA; α-smooth muscle actin; CAF; cancer associated fibroblast; Ca2+; calcium; E2; 17-β-estradiol; ECM; extracellular matrix; EC50; concentration for 50% of maximal effect; EGFR; epidermal growth factor receptor; ER; estrogen receptor; ERK; extracellu
Nrf2 antioxidant defense is involved in survival signaling elicited by 27-hydroxycholesterol in human promonocytic cells
Keywords: ARE; antioxidant response element; CYP27A1; 27-hydroxylase; DAPI; 4,6-diamidino-2-phenylindole; DPI; diphenyleneiodonium chloride; ERK; extracellular signal-regulated kinase; GPx; glutathione peroxidase; GSR; glutathione reductase; HO-1; heme oxygenase-1;
27-Hydroxycholesterol increases Myc protein stability via suppressing PP2A, SCP1 and FBW7 transcription in MCF-7 breast cancer cells
Keywords: Breast cancer; 27-Hydroxycholesterol; Myc protein stability; PP2A; SCP1; FBW7; 27-HC; 27-hydroxycholesterol; E2; 17β-estradiol; ER-α; estrogen receptor alpha; LXR-α; liver X receptor alpha; SERM; selective estrogen receptor modulator; Myc: v-myc avian